Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.47 |
| ▸ | NPR1 | P16066 | 1/20 | 0.45 |
| ▸ | NPR3 | P17342 | 1/20 | 0.45 |
| ▸ | CTSG | P08311 | 2/20 | 0.43 |
| ▸ | F11 | P03951 | 2/20 | 0.42 |
| ▸ | TSLP | Q969D9 | 2/20 | 0.42 |
| ▸ | BECN1 | Q14457 | 3/20 | 0.42 |
| ▸ | TNFSF11 | O14788 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.41 |
| ▸ | BAD | Q92934 | 2/20 | 0.41 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.41 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.41 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.41 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.41 |
| ▸ | MC4R | P32245 | 1/20 | 0.41 |
| ▸ | MC3R | P41968 | 1/20 | 0.41 |
| ▸ | MC1R | Q01726 | 1/20 | 0.41 |
| ▸ | PLAU | P00749 | 2/20 | 0.41 |
| ▸ | KLK7 | P49862 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14029125 | 0.87 | CTSG (0.50) | ALBNPR1NPR3CTSGF11 | |
| SCHEMBL9909406 | 0.84 | ALB (0.47) | ALBNPR1NPR3CTSGF11 | |
| SCHEMBL7010763 | 0.83 | TSLP (0.43) | ALBNPR1NPR3CTSGF11 | |
| SCHEMBL16325464 | 0.83 | ALB (0.46) | ALBNPR1NPR3CTSGTSLP | |
| SCHEMBL13590621 | 0.83 | ALB (0.48) | ALBNPR1NPR3CTSGF11 | |
| SCHEMBL13487337 | 0.83 | NPR1 (0.47) | ALBNPR1NPR3CTSGF11 | |
| SCHEMBL10327614 | 0.81 | NPR1 (0.48) | ALBNPR1NPR3CTSGF11 | |
| SCHEMBL16418037 | 0.81 | NPR1 (0.48) | ALBNPR1NPR3CTSGF11 | |
| SCHEMBL13267689 | 0.81 | NPR1 (0.48) | ALBNPR1NPR3CTSGF11 | |
| SCHEMBL13486079 | 0.80 | NPR1 (0.51) | ALBNPR1NPR3CTSGF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8299030-B2 | Peptide-based compounds | GE HEALTHCARE LIMITED (GB) | 2012-10-30 | — | — | US | disclosed |
| US-20120020882-A1 | PEPTIDE-BASED COMPOUNDS | GE HEALTHCARE AS (NO) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120020882-A1 | PEPTIDE-BASED COMPOUNDS | ITGB3, ITGAV, SELPLG | ALB 4118/4885NPR1 377/4885NPR3 484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.